- Touchlight is the world’s first CDMO to receive a GMP license for the manufacturing of cell-free DNA. Based in Hampton, UK, Touchlight continues to set the standard for cell-free DNA in advanced therapies, including mRNA.
- Clinically adopted Cell-free DNA, dbDNA™: Delivering unprecedented speed and scale—our dbDNA is cost effective, faster, and more sustainable than traditional plasmid with multiple customer candidates in the clinic.
- Expertise that leads the industry: Backed by a world-class team of scientists, engineers, and regulatory experts, Touchlight brings deep technical knowledge and a pioneering spirit to every stage of advanced therapeutic development.